In serum-stimulated liver cancer (HepG2, HuH7, and SK-Hep1) and breast cancer (MCF7) cells, knockdown of cyclin D1 led to decreased cell cycle progression (as measured by DNA synthesis) and diminished lactate production (Fig. S1). This evidence concerns the gene CCND1 and breast carcinoma.